Immediate opportunity in the $10.2 billion U.S. market as the diabetes therapy will be manufactured at Zydus’ SEZ Ahmedabad facility
New filtration lines will boost global drug supply and strengthen India’s role in Merck’s manufacturing network
As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline
Analysis of over 93 lakh preventive health checkups reveals disease risks emerging as early as the 20s
As part of the deal, Red Nucleus also gains indirect ownership of the company’s Indian arm
Collaboration to study integration of AI-enabled VR solutions into medical and nursing curricula
Wholly owned subsidiary KIMS Swastha signs hospital management and sub-lease deal for 210-bed facility, with option to acquire majority stake later
The deal gives Cupid immediate access to Style Baazar’s fast-growing network of over 260 stores
The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred
Subscribe To Our Newsletter & Stay Updated
